Delivery Order SPE2DB20D3111-SPE2DB25FA8SF
- Not listed
- This federal contract award is for the delivery of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML medical products to the Defense Logistics Agency (DLA), a defense agency. The $1,285.14 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,446.40 order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a pharmaceutical product, with a performance period through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on a single award indefinite delivery contract (IDC) valued at up to $999,999,999.00 with DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, valued at $1,070.95, with a completion date of February 11, 2025. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) for the delivery of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a pharmaceutical product. The firm fixed price delivery order has a potential value of $1,198.12 and a performance completion date of January 22, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp has a history of providing pharmaceutical products and...
- The Defense Logistics Agency Troop Support Medical awarded a $268,750 delivery order to Amerisourcebergen Drug Corporation for Tubersol 5T vaccine units. The firm fixed price order is for delivery of 0.1 ml vials of the vaccine to a location in Conshohocken, Pennsylvania. Performance will take place between July 11-12, 2023. No additional details were provided about the original solicitation or whether this delivery order is associated with an existing contract vehicle. The prime contractor is...
- The Defense Logistics Agency Troop Support Medical awarded a $107,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 5,000 units of Tubersol vaccine in 0.1 ml vials. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the vaccines to a location in Conshohocken, Pennsylvania by August 24, 2023 to support DLA Troop Support Medical's medical supply needs. No additional subcontractors or set aside designations were identified in...
- The Defense Logistics Agency awarded a $2,072.80 delivery order to AmerisourceBergen Drug Corp for APLISOL 5T units (0.1 mL vials, 5 mL quantity) with an ultimate completion date of August 1, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the prime contractor. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $18,881.66 to AmerisourceBergen Drug Corp for the supply of TENIVAC vials (0.5ML) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award, with performance to be executed from the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 30, 2025, represents a $1,576.31 firm fixed-price procurement from the Defense Logistics Agency's Medical Supply Chain. The contract is unset-aside and competitively awarded, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of July 31, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,751.04 to AmerisourceBergen Drug Corp on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price, competitively awarded contract (No. 4568924057) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The vendor, headquartered in Conshohocken, Pennsylvania, will perform services at its corporate office...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA8SFDelivery Order
The Defense Logistics Agency awarded a $1,070.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for TUBERSOL 5T Unit/0.1 ML Vial 5ML, a tuberculosis skin test antigen used for diagnostic purposes. This non-set-aside competitive award is scheduled for completion by July 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The company has demonstrated capability to meet federal procurement requirements through competitive awards, with its DLA contract portfolio encompassing specialty medications, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This delivery order represents a routine pharmaceutical procurement under the company's established prime vendor relationship with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/29/25 |